November 7, 2016

FDA’s Final Rule Regarding Device Establishment Registration and Listing

IndiaProduction

IndiaProduction

Recommended Reports

KOL Perspectives: Views on initial Phase III data for etrolizumab in IBD

GPI Anchored Wall Transfer Protein 1 (PfGWT1 or EC 2.3.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Atrial Natriuretic Peptide Receptor 1 (Atrial Natriuretic Peptide Receptor Type A or Guanylate Cyclase A or NPR1 or EC 4.6.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Endothelin 1 Receptor (Endothelin A Receptor or EDNRA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

View All

More

Medical Technology UK 2023

International congress on pediatrics neonatal and nursing care, Prague

Outsourcing in Clinical Trials: Medical Devices USA 2023

Outsourcing in Clinical Trials West Coast (& device stream) 2023